Carlsmed (CARL) Operating Expenses (2024 - 2026)

Carlsmed has reported Operating Expenses for 3 years, with the latest figure at $21.7 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 62.49% year-over-year to $21.7 million; the trailing twelve-month figure through Mar 2026 stood at $77.0 million (up 58.58% YoY), and the FY2025 full-year result was $68.6 million, up 55.34% from the prior year.
• Operating Expenses for Q1 2026 stood at $21.7 million, up from $20.9 million in the prior quarter.
• The five-year high for Operating Expenses was $21.7 million in Q1 2026, with the low at $10.9 million in Q2 2024.
• Historically, Operating Expenses has averaged $15.7 million across 3 years, with a median of $14.4 million in 2025.
• The largest YoY upside for Operating Expenses was 78.53% in 2025 against a maximum downside of 41.26% in 2025.
• Carlsmed's Operating Expenses stood at $11.7 million in 2024, then soared by 78.53% to $20.9 million in 2025, then rose by 3.7% to $21.7 million in 2026.
• The last three Operating Expenses figures came in at $21.7 million (Q1 2026), $20.9 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.